Abstract

Blood pressure (BP) is a typical complex trait, and the genetic susceptibility of individuals to changes in BP induced by air pollution exposure is different. Although interactions of exposure to air pollutants with several candidate genes have been identified, genome-wide interaction studies (GWISs) are needed to understand the association between them with BP. Therefore, we aimed to discover the unique genetic loci for BP that interact with exposure to air pollutants in Korean adults. We ultimately included 1868 participants in the discovery step and classified them into groups of those with low-to-moderate exposure and high exposure to average annual concentration of particulate matter with an aerodynamic diameter ≤ 10 μm (PM10). Because none of the single nucleotide polymorphisms (SNPs) achieved a genome-wide level of significance of pint < 5 × 10–8 for either systolic BP (SBP) or diastolic BP (DBP), we considered the top 10 ranking SNPs for each BP trait. To validate these suggestive SNPs, we finally selected six genetic variants for SBP and five variants for DBP, respectively. In a replication result for SBP, only one SNP (rs12914147) located in an intergenic region of the NR2F2 showed a significant interaction. We also identified several genetic susceptibility loci (e.g., CHST11, TEK, and ITGA1) implicated in candidate mechanisms such as inflammation and oxidative stress in the discovery step, although their interaction effects were not replicated. Our study reports the first GWIS finding to our knowledge, and the association between exposure to PM10 and BP levels may be determined in part by several newly discovered genetic suggestive loci, including NR2F2.

Details

Title
A genome-wide by PM10 exposure interaction study for blood pressure in Korean adults
Author
Kim, Hyun-Jin 1 ; Son, Ho-young 2 ; Park, Philiip 1 ; Yun, Jae Moon 3 ; Kwon, Hyuktae 3 ; Cho, Belong 4 ; Kim, Jong-Il 5 ; Park, Jin-Ho 4 

 National Cancer Center, National Cancer Control Institute, Goyang, South Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810) 
 Seoul National University, Genomic Medicine Institute, Medical Research Center, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University Hospital, Department of Family Medicine, Seoul, South Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X) 
 Seoul National University Hospital, Department of Family Medicine, Seoul, South Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X); Seoul National University College of Medicine, Department of Family Medicine, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University, Genomic Medicine Institute, Medical Research Center, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University Graduate School, Department of Biomedical Sciences, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University College of Medicine, Department of Biochemistry & Molecular Biology, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University College of Medicine, Cancer Research Institute, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
Pages
13060
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2849187507
Copyright
© Springer Nature Limited 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.